NASDAQ: GNLXGenelux Corp Stock Ownership - Who owns Genelux?
Insider buying vs selling
Have Genelux Corp insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Yong Yu | VP Clinical Trial Operations | 2025-05-12 | 5,579 | $2.92 | $16.29kSell |
| Sean Ryder | General Counsel | 2025-05-12 | 4,475 | $2.92 | $13.07kSell |
| Joseph Cappello | VP Pharmaceutical Development | 2025-05-12 | 4,737 | $2.92 | $13.83kSell |
| Ralph Smalling | Head of Regulatory | 2025-05-12 | 1,259 | $2.92 | $3.68kSell |
| Thomas Zindrick | President and CEO | 2025-05-12 | 10,764 | $2.92 | $31.43kSell |
| James L. Tyree | Director | 2024-12-30 | 3,460 | $2.46 | $8.51kSell |
| Joseph Cappello | VP Pharmaceutical Development | 2024-12-16 | 6,300 | $2.34 | $14.74kSell |
| Ralph Smalling | Head of Regulatory | 2024-12-16 | 2,510 | $2.34 | $5.87kSell |
| Lourie S. Zak | Chief Financial Officer | 2024-12-16 | 2,103 | $2.34 | $4.92kSell |
| Thomas Zindrick | President and CEO | 2024-12-16 | 14,315 | $2.34 | $33.50kSell |
GNLX insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when GNLX insiders and whales buy or sell their stock.
GNLX Shareholders
What type of owners hold Genelux Corp stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Woodward Diversified Capital LLC | 4.71% | 1,778,286 | $6.72M | Institution |
| Vanguard Group Inc | 3.85% | 1,453,846 | $5.50M | Institution |
| Bleichroeder LP | 1.89% | 714,000 | $2.70M | Institution |
| Aladar Szalay | 1.47% | 555,000 | $2.10M | Insider |
| John Thomas | 1.27% | 480,501 | $1.82M | Insider |
| Bank Of America Corp | 1.08% | 408,692 | $1.54M | Institution |
| Thomas Zindrick | 1.04% | 391,447 | $1.48M | Insider |
| Blackrock Inc | 0.86% | 324,983 | $1.23M | Institution |
| Geode Capital Management LLC | 0.84% | 318,825 | $1.21M | Institution |
| Alyeska Investment Group LP | 0.76% | 285,000 | $1.08M | Institution |
GNLX vs Biotech Stocks
Genelux Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.